Concord Repatriation General Hospital — Concord

Public research footprint of Concord Repatriation General Hospital, compiled from the ClinicalTrials.gov public registry.

216

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Chronic Lymphocytic Leukemia · Hormone Receptor Positive HER-2 Negative Breast Cancer · Non-Small Cell Lung Cancer (NSCLC) · Diffuse Large B Cell Lymphoma

Recently updated registry entries

NCT07196748 — A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to… (Recruiting)
NCT07196722 — A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease (Recruiting)
NCT06152575 — MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Concord Repatriation General Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.